The goal of this clinical trial is to learn if the I-arch system works to align the moderately misaligned teeth in patients seeking orthodontic treatment. it aims to answer the following questions: * Does I-arch system increase the rate of teeth alignment? * Does I-arch system produce significant changes in arch width and incisors inclination? * Does I-arch system decrease the intensity of patient-reported pain and root resorption? Researchers will compare the effectiveness of the I-arch and MBT arch wire system.
This study will be a multicenter non-stratified prospective randomized clinical trial designed as a blinded, parallel group trial with equal randomization (1:1 allocation ratio). It will be conducted at multiple orthodontic centers. Initially, the eligibility of the patients to participate in this study will be evaluated by the investigator. Verbal information about the nature of study will be supplied for those who will satisfy the inclusion criteria to obtain their preliminary approval. Then the patient information sheet and consent form will be given to the patients to read carefully at home to decide whether they will participate in the study at the following visit. Patient assent/parental consent will be taken for participants below 18 years. If the patients have any queries regarding the study, the investigator should resolve it on the following visit. Orthodontic treatment will be conducted using a straight wire appliance. MBT prescription brackets with 0.018-inch slot (Microfit™, SIA Orthodontic Manufacturer, Italy) will be used. With the aid of a height gauge, standardized bracket placement will be achieved. The technique will begin with a 10-second prophylactic procedure to clean and polish the teeth surfaces with pumice and a rubber cup using a slow-speed handpiece. Then, teeth will be rinsed with water and dried with oil-free air spray for 30 seconds. For the purpose of standardization, bonding procedure will be as followed: * The enamel surface will be etched with 37% phosphoric acid gel for 30 seconds. * The acid etchant will be rinsed off with water spray thoroughly. * The tooth surface will be dried by air spray until the white frosty appearance of the etched surface is seen. * A thin layer of Light Bond™ Sealant (Reliance®, Itasca, USA) will be applied on the etched enamel surface for one minute, then air will be applied for 5 seconds. * Brackets and tubes will be bonded using Light Bond™ light cure orthodontic adhesive (Reliance®, Itasca, USA) which applied on their bases and light-cured above interproximal contacts at a distance of 2-3 mm (5 seconds mesially and 5 seconds distally for brackets and 10 seconds mesially and 10 seconds occlusally for molar tubes). Arch wire sequence for each group will be as follows: 1. I-arch system group (I-arch™ Orthodontic System, SIA Orthodontic Manufacturer, Italy. ( • 0.016×0.014-inch copper nickel titanium. 2. MBT arch wire system group (Thermal NiTi™, SIA Orthodontic Manufacturer, Italy) * 0.014-inch heat-activated nickel titanium. * 0.016-inch heat-activated nickel titanium. A standardized protocol will be followed during the treatment for all the participants. At the day of bonding, 0.016×0.014 copper nickel titanium arch wire will be placed for the I-arch group and religated every four weeks. While, for the MBT group, 0.014-inch heat-activated nickel titanium arch wire will be placed at the day of bonding, then after 8 weeks it will be replaced by the 0.016-inch heat-activated nickel titanium arch wire for another 8 weeks (both will be religated every four weeks). Elastomeric modules will be used for ligating the wire to the brackets. If any bracket debonding occurs throughout the course of the treatment, it should be bonded again during 24 hours. Otherwise, the participant will be excluded from the trial. Since this study will be performed during the initial phase of treatment, no deviation from the protocol of treatment will be accepted (such as adding additional arch wire in the sequence or using power chain). Digital scan for the maxillary and mandibular arches will be taken pre-treatment and after 4, 8, 12 and 16 weeks, and a digital model will be obtained which will be used to measure Little's irregularity index, the intercanine and intermolar widths. Lateral cephalometric radiograph and periapical radiographs (for the maxillary and mandibular central incisors) will be taken pre-treatment and after 16 weeks. Lateral cephalometric radiographs will be used to measure the inclination of the maxillary and mandibular incisors. While the periapical radiographs will be used to assess the root resorption of the maxillary and mandibular central incisors. The participants will be supplied with a visual analog scale (0-10) to record their pain perception during the first seven days following the first wire placement. At the end of the trial, the treatment will continue as prescribed.
Teeth alignment using an initial arch wire with a rectangular switched cross-section since the beginning of the treatment.
Teeth alignment using initial arch wires with round cross sections.
The rate of alignment
Alignment rate will be measured using Little's Irregularity Index on digital dental models.
Time frame: 16 weeks
The amount of inclination of the incisors
Maxillary and mandibular incisors inclination will be measured on lateral cephalometric radiographs.
Time frame: 16 weeks
The change in the width of dental arches
Maxillary and mandibular intermolar and intercanine widths will be measured on digital dental models.
Time frame: 16 weeks
The amount of root resorption
the root resorption of the maxillary and mandibular central incisors will be assessed on periapical radiographs using the long cone paralleling technique.
Time frame: 16 weeks
The intensity of pain
Pain intensity will be measured using visual analog scale.
Time frame: Throughout the seven days following the insertion of the first arch wire
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
30